Internal Medicine, Clinical Cardiatric Electrophysiology · Chico, CA
NPI
1619935079
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1645 Esplanade, Suite 3
Chico, CA, 95926
Phone (530) 893-8806
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
10,516 services
Medicare patients, 2024
777
Average age 76
Drug cost, 2024
$357K
1,012 prescriptions
Company payments, 2025
$934
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walter T Kusumoto was code 99426 (chronic, principal, and transitional care management), 1,912 times for 278 patients. In total Walter T Kusumoto billed 10,516 services in 62 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99426 Chronic, Principal, and Transitional Care Management | Office | 1,912 | 278 | $48.68 | $93K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,204 | 187 | $49.44 | $60K |
| 99213 Office E&M - Established | Office | 1,192 | 602 | $65.30 | $78K |
| 93298 External Electrocardiographic Monitoring | Office | 774 | 119 | $71.52 | $55K |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 742 | 249 | $37.58 | $28K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 569 | 172 | $38.11 | $22K |
| 93000 Electrocardiogram | Office | 559 | 261 | $10.18 | $5,689 |
| 93280 External Electrocardiographic Monitoring | Office | 403 | 167 | $57.47 | $23K |
| 99214 Office E&M - Established | Office | 393 | 272 | $95.74 | $38K |
| 99215 Office E&M - Established | Office | 353 | 218 | $134.03 | $47K |
| 93284 External Electrocardiographic Monitoring | Office | 310 | 88 | $76.77 | $24K |
| 93285 External Electrocardiographic Monitoring | Office | 293 | 129 | $44.92 | $13K |
| 93282 External Electrocardiographic Monitoring | Office | 289 | 95 | $55.21 | $16K |
| 93283 External Electrocardiographic Monitoring | Office | 142 | 46 | $71.79 | $10K |
| 93623 Comprehensive Electrophysiologic Evaluation | Facility | 113 | 107 | $50.97 | $5,760 |
By year: 2022 $773K for 7,562 services; 2023 $979K for 11,457 services; 2024 $1.0M for 10,516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Walter T Kusumoto prescribed most often to Medicare patients was Eliquis (Apixaban), with 206 prescriptions and refills. In total Walter T Kusumoto wrote 1,012 Medicare prescriptions that cost $357K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 206 | 356 | 50 | $202K |
| Flecainide Acetate Generic | 135 | 341 | 50 | $7,744 |
| Amiodarone Hcl Generic | 127 | 307 | 40 | $5,592 |
| Enoxaparin Sodium Generic | 112 | 112 | 94 | $4,928 |
| Xarelto Rivaroxaban | 67 | 89 | 11 | $48K |
| Metoprolol Succinate Generic | 59 | 161 | 23 | $869 |
| Sotalol Sotalol Hcl | 46 | 138 | 13 | $1,217 |
| Disopyramide Phosphate Generic | 39 | 71 | Under 11 | $11K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 39 | 103 | 13 | $1,073 |
| Diltiazem 24hr Er Diltiazem Hcl | 27 | 57 | Under 11 | $739 |
| Multaq Dronedarone Hcl | 25 | 66 | Under 11 | $49K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 23 | 23 | 23 | $104 |
| Diltiazem Hcl Generic | 16 | 40 | Under 11 | $412 |
| Nadolol Generic | 12 | 14 | Under 11 | $514 |
Brand drugs: 341 claims; generic drugs: 671 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walter T Kusumoto $934 ($934 in general payments such as food, travel and fees) from 8 companies. The largest payer was Biosense Webster, Inc. with $247.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.